{"id":58472,"date":"2024-02-27T18:37:42","date_gmt":"2024-02-27T18:37:42","guid":{"rendered":"https:\/\/medsname.com\/cozartan-h\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"cozartan-h","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/cozartan-h\/","title":{"rendered":"Cozartan-H"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Cozartan-H?<\/h3>\n<p style=\"margin:0;\"><strong>Cozartan-H<\/strong> je <strong>50\/12.5 mg fixed-dose tablet<\/strong> of losartan 50 mg and <strong>hydrochlorothiazid<\/strong> od Torrent Pharmaceuticals \u2014 <strong>kombinace antihypertenziv 2. volby<\/strong> pro pacienty, jejich\u017e krevn\u00ed tlak nen\u00ed kontrolov\u00e1n <a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar<\/a> (losartan monotherapy) alone. Adding a thiazide diuretic typically yields an additional <strong>pokles systolick\u00e9ho tlaku o 5-10 mmHg<\/strong> ve srovn\u00e1n\u00ed s monoterapi\u00ed ARB. Ob\u011b slo\u017eky p\u016fsob\u00ed prost\u0159ednictv\u00edm <strong>komplement\u00e1rn\u00edch mechanism\u016f<\/strong> (ARB blokuje receptor pro angiotensin-II; HCTZ odstra\u0148uje sod\u00edk a vyvol\u00e1v\u00e1 m\u00edrnou volumovou kontrakci) a maj\u00ed <strong>vz\u00e1jemn\u011b vyva\u017euj\u00edc\u00ed profily vedlej\u0161\u00edch \u00fa\u010dink\u016f<\/strong> \u2014 HCTZ sni\u017euje hladinu drasl\u00edku, zat\u00edmco ARB ji m\u00e1 tendenci zvy\u0161ovat, tak\u017ee kombinace je m\u00e9n\u011b pravd\u011bpodobn\u00e1 p\u0159i vzniku hypokal\u00e9mie nebo hyperkal\u00e9mie ne\u017e ka\u017ed\u00fd l\u00e9k samostatn\u011b v ekvivalentn\u00edch d\u00e1vk\u00e1ch. Obvykl\u00e9 d\u00e1vkov\u00e1n\u00ed: jedna tableta jednou denn\u011b. <strong>Absolutn\u011b kontraindikov\u00e1n v t\u011bhotenstv\u00ed<\/strong> (ob\u011b slo\u017eky), <strong>anurie nebo t\u011b\u017ek\u00e9 ren\u00e1ln\u00ed posti\u017een\u00ed (eGFR &lt;30)<\/strong>, <strong>p\u0159ecitliv\u011blost na thiazidy (sulfonamidy)<\/strong>, a <strong>symptomatick\u00e1 hyponatr\u00e9mie<\/strong>. Monitorujte drasl\u00edk, sod\u00edk, ur\u00e1ty a kreatinin b\u011bhem l\u00e9\u010dby.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">What Is Cozartan-H?<\/h2>\n<p>Cozartan-H is an oral fixed-dose combination tablet supplying <strong>losartan 50 mg<\/strong> a <strong>hydrochlorothiazid (HCTZ)<\/strong> in a single pill, made by Torrent Pharmaceuticals and supplied in 30-180 tablets. It combines two first-line antihypertensive drug classes in a ratio chosen for most patients who have progressed beyond ARB monotherapy. Losartan is the <strong>first ARB approved for clinical use<\/strong> (DuPont Merck 1995; originator brand Cozaar). Half-life ~2 hours for the parent drug and 6-9 hours for the active metabolite E-3174 (generated by CYP2C9 and CYP3A4).<\/p>\n<p>Hydrochlorothiazid (HCTZ) je thiazidov\u00e9 diuretikum zaveden\u00e9 v roce 1959 (MSD jako HydroDiuril). St\u00e1le pat\u0159\u00ed mezi nej\u010dast\u011bji p\u0159edepisovan\u00e1 antihypertenziva na sv\u011bt\u011b a je <strong>\u010dtvrtou t\u0159\u00eddou doporu\u010denou v guidelines<\/strong> pro hypertenzi vedle ARB, ACE inhibitor\u016f a blok\u00e1tor\u016f kalciov\u00fdch kan\u00e1l\u016f.<\/p>\n<h2 class=\"wp-block-heading\">Pro\u010d kombinovat ARB s thiazidem?<\/h2>\n<p>Hypertenze je jen z\u0159\u00eddka kontrolov\u00e1na jedin\u00fdm l\u00e9kem v c\u00edlov\u00e9 d\u00e1vce. Studie jako ALLHAT, ACCOMPLISH a ASCOT prok\u00e1zaly, \u017ee <strong>v\u011bt\u0161ina hypertonik\u016f pot\u0159ebuje dva nebo t\u0159i l\u00e9ky z r\u016fzn\u00fdch t\u0159\u00edd<\/strong> k dosa\u017een\u00ed c\u00edlov\u00fdch hodnot krevn\u00edho tlaku dle doporu\u010den\u00ed (&lt;140\/90 u v\u011bt\u0161iny dosp\u011bl\u00fdch, &lt;130\/80 u diabetik\u016f a pacient\u016f s CKD). Kombinace ARB + thiazid je jednou ze t\u0159\u00ed v\u011bdecky podlo\u017een\u00fdch dvoul\u00e9kov\u00fdch kombinac\u00ed (dal\u0161\u00ed dv\u011b jsou ARB + CCB a CCB + thiazid).<\/p>\n<p>The two components of Cozartan-H complement each other on <strong>\u010dty\u0159ech farmakologick\u00fdch os\u00e1ch<\/strong>:<\/p>\n<ul>\n<li><strong>Dopl\u0148kov\u00e9 mechanismy sni\u017eov\u00e1n\u00ed krevn\u00edho tlaku.<\/strong> ARB blokuje vazokonstrikci a aldosteronem \u0159\u00edzenou retenci sod\u00edku; HCTZ sni\u017euje celkov\u00fd obsah sod\u00edku v t\u011ble a zp\u016fsobuje m\u00edrnou volumovou kontrakci. Aditivn\u00ed pokles krevn\u00edho tlaku (typicky o 5-10 mmHg systolick\u00e9ho tlaku nav\u00edc oproti monoterapii ARB).<\/li>\n<li><strong>RAAS kontra-regulace.<\/strong> Thiazidy aktivuj\u00ed syst\u00e9m renin-angiotenzin-aldosteron jako kompenza\u010dn\u00ed odpov\u011b\u010f na ztr\u00e1tu sod\u00edku \u2014 to obvykle tlum\u00ed jejich \u00fa\u010dinek. Blokov\u00e1n\u00ed AT<sub>1<\/sub> receptoru pomoc\u00ed ARB <strong>zabra\u0148uje t\u00e9to kompenza\u010dn\u00ed aktivaci<\/strong> a odemyk\u00e1 pln\u00fd antihypertenzn\u00ed \u00fa\u010dinek thiazidu.<\/li>\n<li><strong>Bilance drasl\u00edku.<\/strong> HCTZ ztr\u00e1c\u00ed drasl\u00edk p\u0159es dist\u00e1ln\u00ed tubulus (klasick\u00e9 riziko hypokal\u00e9mie). ARB zvy\u0161uj\u00ed hladinu drasl\u00edku blokov\u00e1n\u00edm aldosteronem zprost\u0159edkovan\u00e9 exkrece drasl\u00edku. Kombinace proto udr\u017euje fyziologi\u010dt\u011bj\u0161\u00ed hladinu drasl\u00edku ne\u017e ka\u017ed\u00fd l\u00e9k samostatn\u011b \u2014 klinicky se to projevuje m\u00e9n\u011b epizodami hypokal\u00e9mie p\u0159i kombinovan\u00e9 terapii s kli\u010dkov\u00fdmi diuretiky a m\u00e9n\u011b klinicky v\u00fdznamn\u00fdmi hyperkalemiemi ne\u017e u monoterapie ARB.<\/li>\n<li><strong>Kontra-regulace volumov\u00e9 aktivace.<\/strong> Vazodilatace vyvolan\u00e1 ARB m\u016f\u017ee u pacient\u016f citliv\u00fdch na s\u016fl vyvolat retenci sod\u00edku (klasick\u00e1 p\u0159\u00ed\u010dina \u201cztracen\u00e9\u201d odpov\u011bdi na krevn\u00ed tlak po t\u00fddnech l\u00e9\u010dby). Natriur\u00e9za zp\u016fsoben\u00e1 HCTZ tuto reten\u010dn\u00ed smy\u010dku p\u0159eru\u0161uje.<\/li>\n<\/ul>\n<p>Losartan is <strong>uniquely uricosuric among ARBs<\/strong> &mdash; it lowers serum uric acid by inhibiting the URAT1 transporter in the proximal tubule. This is clinically important in this combination, because <strong>HCTZ raises serum uric acid<\/strong> by competing for the same excretory pathway. The losartan-HCTZ combination is therefore <strong>the preferred ARB+thiazide pairing for patients with gout, hyperuricaemia, or who are sensitive to thiazide-induced urate rises<\/strong>.<\/p>\n<p><strong>D\u016fkazy pro ARB+HCTZ:<\/strong> The <strong>studie LIFE (2002)<\/strong> used losartan with HCTZ add-on as its active arm, demonstrating a 13% reduction in stroke, cardiovascular death, and myocardial infarction versus atenolol-based therapy in hypertensive patients with left-ventricular hypertrophy. RENAAL (2001) established renoprotection in type 2 diabetic nephropathy.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed &amp; Titrace<\/h2>\n<p><strong>Standardn\u00ed d\u00e1vka:<\/strong> one 50\/12.5 mg tablet once daily, typically in the morning (HCTZ causes a mild diuresis; evening dosing can disrupt sleep with night-time urination).<\/p>\n<p><strong>When to start Cozartan-H:<\/strong><\/p>\n<ul>\n<li>BP not controlled on losartan 50 mg monotherapy after 4-6 weeks at target dose<\/li>\n<li>Hypertenze 2. stupn\u011b (\u2265160\/100) jako po\u010d\u00e1te\u010dn\u00ed kombinace \u2014 zah\u00e1jen\u00ed dvou l\u00e9k\u016f z r\u016fzn\u00fdch t\u0159\u00edd je preferov\u00e1no p\u0159ed titrac\u00ed jednoho l\u00e9ku u t\u011b\u017ek\u00e9 hypertenze dle doporu\u010den\u00ed AHA\/ACC<\/li>\n<li>P\u0159echod z kombinace ACE inhibitor\/HCTZ, pokud ACE inhibitor zp\u016fsobil ka\u0161el<\/li>\n<\/ul>\n<p><strong>Titrace:<\/strong> Pokud TK z\u016fst\u00e1v\u00e1 nekontrolovan\u00fd po 4-6 t\u00fddnech na po\u010d\u00e1te\u010dn\u00ed FDC, lze nahradit tabletou s vy\u0161\u0161\u00ed silou (v\u011bt\u0161ina v\u00fdrobc\u016f nab\u00edz\u00ed kombinace 50\/12,5, 100\/12,5, 80\/12,5, 160\/12,5 a 160\/25 p\u0159\u00edslu\u0161n\u00e9ho ARB s HCTZ). P\u0159\u00edpadn\u011b p\u0159idat t\u0159et\u00ed t\u0159\u00eddu \u2014 typicky <a href=\"https:\/\/medsbase.com\/cs\/amlode\/\">blok\u00e1tor kalciov\u00fdch kan\u00e1l\u016f (amlodipin)<\/a>.<\/p>\n<p><strong>Monitorovac\u00ed pl\u00e1n:<\/strong><\/p>\n<ul>\n<li><strong>Vstupn\u00ed vy\u0161et\u0159en\u00ed:<\/strong> mo\u010dovina, elektrolyty (sod\u00edk, drasl\u00edk), kreatinin, eGFR, s\u00e9rov\u00fd ur\u00e1t, glyk\u00e9mie nala\u010dno, lipidy. Dom\u00e1c\u00ed nebo ambulantn\u00ed m\u011b\u0159en\u00ed TK.<\/li>\n<li><strong>1-2 t\u00fddny po zah\u00e1jen\u00ed nebo zm\u011bn\u011b d\u00e1vky:<\/strong> opakovat U&amp;E. O\u010dek\u00e1vejte m\u00edrn\u00fd vzestup kreatininu (a\u017e 30 % je p\u0159ijateln\u00e9), m\u00edrn\u00fd pokles sod\u00edku (1\u20133 mmol), m\u00edrn\u00fd vzestup ur\u00e1t\u016f (\u010d\u00e1ste\u010dn\u011b kompenzov\u00e1no u p\u0159\u00edpravk\u016f obsahuj\u00edc\u00edch losartan). Drasl\u00edk obvykle stabiln\u00ed v norm\u00e1ln\u00edm rozmez\u00ed.<\/li>\n<li><strong>4-6 t\u00fddn\u016f:<\/strong> kontrola TK k posouzen\u00ed odpov\u011bdi; opakovat U&amp;E p\u0159i jak\u00e9koli poru\u0161e elektrolyt\u016f v d\u0159\u00edv\u011bj\u0161\u00edm \u010dasov\u00e9m bod\u011b.<\/li>\n<li><strong>Pr\u016fb\u011b\u017en\u00e9:<\/strong> ro\u010dn\u00ed U&amp;E, ur\u00e1ty, gluk\u00f3za a lipidy po stabilizaci. Dom\u00e1c\u00ed m\u011b\u0159en\u00ed TK dvakr\u00e1t t\u00fddn\u011b.<\/li>\n<li><strong>P\u0159eru\u0161te a vy\u0161et\u0159ete:<\/strong> symptomatick\u00e1 hyponatr\u00e9mie (zmatenost, nauzea, letargie; s\u00e9rov\u00fd Na &lt;130), drasl\u00edk 5,5, vzestup kreatininu &gt;30 %, nov\u00e1 nebo zhor\u0161uj\u00edc\u00ed se dna, hypersenzitivn\u00ed vyr\u00e1\u017eka.<\/li>\n<\/ul>\n<p><strong>Ukon\u010den\u00ed l\u00e9\u010dby:<\/strong> \u017e\u00e1dn\u00fd abstinen\u010dn\u00ed syndrom, ale n\u00e1hl\u00e9 vysazen\u00ed zp\u016fsob\u00ed postupn\u00fd n\u00e1vrat TK b\u011bhem dn\u016f. Postupn\u00e9 vysazen\u00ed nahrazen\u00edm kombinac\u00ed s ni\u017e\u0161\u00ed silou nebo n\u00e1vrat k monoterapii ARB pod kontrolou TK.<\/p>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p>Vedlej\u0161\u00ed \u00fa\u010dinky se p\u0159ekr\u00fdvaj\u00ed s \u00fa\u010dinky obou slo\u017eek l\u00e9ku. Kombinace je obvykle <strong>l\u00e9pe sn\u00e1\u0161ena<\/strong> ne\u017e kter\u00e1koli slo\u017eka v maxim\u00e1ln\u00ed d\u00e1vce monoterapie, proto\u017ee d\u00e1vky pou\u017e\u00edvan\u00e9 v fixn\u00edch kombinac\u00edch jsou ni\u017e\u0161\u00ed ne\u017e \u0161pi\u010dkov\u00e9 d\u00e1vky monoterapie.<\/p>\n<p><strong>\u010cast\u00e9 (&gt;1 % u\u017eivatel\u016f):<\/strong><\/p>\n<ul>\n<li>Z\u00e1vrat\u011b, ortostatick\u00e1 hypotenze (obvykle m\u00edrn\u00e1; \u010dast\u011bj\u0161\u00ed v prvn\u00edch 1\u20132 t\u00fddnech)<\/li>\n<li>M\u00edrn\u00e1 diur\u00e9za \u2014 zv\u00fd\u0161en\u00e9 mo\u010den\u00ed v prvn\u00edch dnech, obvykle se uprav\u00ed s vyrovn\u00e1n\u00edm objemu<\/li>\n<li>M\u00edrn\u00e1 hyponatr\u00e9mie nebo hypokal\u00e9mie u n\u00e1chyln\u00fdch pacient\u016f<\/li>\n<li>O\u010dek\u00e1van\u00fd m\u00edrn\u00fd vzestup kreatininu (a\u017e 30 %)<\/li>\n<li>\u00danava, bolest hlavy, nazofaryngitida<\/li>\n<li>Hyperurik\u00e9mie (typicky asymptomatick\u00e1; vz\u00e1cn\u011b vyvol\u00e1 dnu \u2014 m\u00e9n\u011b pravd\u011bpodobn\u00e9 u kombinac\u00ed s losartanem)<\/li>\n<li>Fotosenzitivn\u00ed vyr\u00e1\u017eka (souvisej\u00edc\u00ed s thiazidy)<\/li>\n<\/ul>\n<p><strong>Nep\u0159\u00edli\u0161 \u010dast\u00e9, ale klinicky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>T\u011b\u017ek\u00e1 hyponatr\u00e9mie<\/strong> \u2014 nejvy\u0161\u0161\u00ed riziko u star\u0161\u00edch \u017een na n\u00edzkosoln\u00fdch diet\u00e1ch, se srde\u010dn\u00edm selh\u00e1n\u00edm nebo n\u00e1chyln\u00fdch k SIADH. P\u0159i nov\u011b vznikl\u00fdch stavech zmatenosti, nevolnosti nebo p\u00e1dech vy\u0161et\u0159ete s\u00e9rov\u00fd sod\u00edk.<\/li>\n<li><strong>Vyvol\u00e1n\u00ed akutn\u00ed dny<\/strong> \u2014 pravd\u011bpodobn\u011bj\u0161\u00ed u kombinace valsartan+HCTZ nebo telmisartan+HCTZ ne\u017e losartan+HCTZ. P\u0159i opakovan\u00fdch p\u0159\u00edpadech p\u0159ejd\u011bte na kombinaci s losartanem.<\/li>\n<li><strong>Metabolick\u00e1 porucha<\/strong> \u2014 zhor\u0161en\u00e1 gluk\u00f3zov\u00e1 tolerance (pr\u016fm\u011brn\u00fd vzestup hladiny gluk\u00f3zy nala\u010dno o 5-8 mg\/dL), m\u00edrn\u00e9 zv\u00fd\u0161en\u00ed LDL a triglycerid\u016f. Telmisartan to \u010d\u00e1ste\u010dn\u011b kompenzuje d\u00edky aktivit\u011b PPAR-\u03b3.<\/li>\n<li><strong>Angioed\u00e9m<\/strong> \u2014 ni\u017e\u0161\u00ed v\u00fdskyt ne\u017e u ACE inhibitor\u016f, ale mo\u017en\u00fd. Okam\u017eit\u011b vysa\u010fte; nahra\u010fte ne-RAAS l\u00e9\u010divem.<\/li>\n<li><strong>Akutn\u00ed po\u0161kozen\u00ed ledvin p\u0159i hypovolemick\u00fdch stavech nebo bilater\u00e1ln\u00ed sten\u00f3ze ren\u00e1ln\u00ed arterie<\/strong><\/li>\n<li><strong>Pankreatitida<\/strong> \u2014 vz\u00e1cn\u00fd ne\u017e\u00e1douc\u00ed \u00fa\u010dinek t\u0159\u00eddy thiazid\u016f; p\u0159i jak\u00e9koli bolesti v nadb\u0159i\u0161ku se vzestupem lip\u00e1zy okam\u017eit\u011b vysa\u010fte.<\/li>\n<li><strong>Akutn\u00ed myopie a uzav\u0159en\u00fd \u00fahel glaukomu<\/strong> \u2014 vz\u00e1cn\u00e1 reakce t\u0159\u00eddy sulfonamid\u016f, typicky b\u011bhem hodin a\u017e dn\u016f po zah\u00e1jen\u00ed nov\u00e9ho sulfonamidu. P\u0159i n\u00e1hl\u00e9 bolesti oka nebo zm\u011bn\u011b vid\u011bn\u00ed okam\u017eit\u011b vysa\u010fte a vyhledejte neodkladn\u00e9 oftalmologick\u00e9 vy\u0161et\u0159en\u00ed.<\/li>\n<li><strong>Trombocytopenie, leukopenie<\/strong> \u2014 vz\u00e1cn\u00e9 reakce thiazidov\u00e9 t\u0159\u00eddy<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace<\/h2>\n<ul>\n<li><strong>T\u011bhotenstv\u00ed \u2014 ABSOLUTN\u00cd kontraindikace ve v\u0161ech trimestrech.<\/strong> Ob\u011b slo\u017eky: ARB zp\u016fsobuj\u00ed fet\u00e1ln\u00ed ren\u00e1ln\u00ed agenezi, oligohydramnion, plicn\u00ed hypoplazii; HCTZ p\u0159ech\u00e1z\u00ed placentou a m\u016f\u017ee zp\u016fsobit fet\u00e1ln\u00ed nebo neonat\u00e1ln\u00ed \u017eloutenku a trombocytopenii. P\u0159epn\u011bte na <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, methyldopu nebo nifedipin.<\/li>\n<li><strong>Anurie nebo t\u011b\u017ek\u00e9 ren\u00e1ln\u00ed posti\u017een\u00ed<\/strong> (eGFR &lt;30 ml\/min\/1,73 m\u00b2) \u2014 HCTZ ztr\u00e1c\u00ed \u00fa\u010dinnost p\u0159i n\u00edzk\u00e9 GFR a ARB zvy\u0161uje riziko AKI<sup>2<\/sup>P\u0159ecitliv\u011blost na thiazidy nebo sulfonamidy<\/li>\n<li><strong>Symptomatick\u00e1 hyponatr\u00e9mie (Na &lt;130)<\/strong><\/li>\n<li><strong>p\u0159i vstupn\u00edm vy\u0161et\u0159en\u00ed \u2014 zhor\u0161\u00ed se<\/strong> Symptomatick\u00e1 hypokal\u00e9mie (K &lt;3,0)<\/li>\n<li><strong>nebo hypomagnez\u00e9mie p\u0159i vstupn\u00edm vy\u0161et\u0159en\u00ed \u2014 nejprve korigujte<\/strong> \u2014 HCTZ zvy\u0161uje kalcium sn\u00ed\u017een\u00edm ren\u00e1ln\u00ed exkrece<\/li>\n<li><strong>Hyperkalc\u00e9mie<\/strong> (Child-Pugh C) \u2014 riziko vyvol\u00e1n\u00ed jatern\u00ed encefalopatie prost\u0159ednictv\u00edm posunu elektrolyt\u016f<\/li>\n<li><strong>T\u011b\u017ek\u00e9 jatern\u00ed po\u0161kozen\u00ed<\/strong> Anamn\u00e9za angioed\u00e9mu s jak\u00fdmkoli ACE inhibitorem nebo ARB<\/li>\n<li><strong>(do 4 t\u00fddn\u016f; dlouhodob\u00e9 opatrn\u00e9 u\u017e\u00edv\u00e1n\u00ed je \u010dasto p\u0159ijateln\u00e9 pod odborn\u00fdm dohledem)<\/strong> (within 4 weeks; longer-term cautious use often acceptable under specialist advice)<\/li>\n<li><strong>Bilater\u00e1ln\u00ed sten\u00f3za ren\u00e1ln\u00edch tepen<\/strong><\/li>\n<li><strong>Sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed sacubitrilu\/valsartanu (Entresto)<\/strong> \u2014 vy\u017eaduje 36hodinovou vyplachovac\u00ed pauzu<\/li>\n<li><strong>Sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed aliskirenu u diabetu nebo CKD<\/strong> (po\u0161kozen\u00ed ALTITUDE)<\/li>\n<li><strong>Sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed ACE inhibitoru<\/strong> \u2014 po\u0161kozen\u00ed ONTARGET bez p\u0159\u00ednosu<\/li>\n<\/ul>\n<p><strong>Kojen\u00ed:<\/strong> HCTZ se vylu\u010duje do ml\u00e9ka a m\u016f\u017ee potla\u010dovat laktaci p\u0159i vy\u0161\u0161\u00edch d\u00e1vk\u00e1ch; obecn\u011b se vyh\u00fdb\u00e1 v prvn\u00edch t\u00fddnech po porodu p\u0159ed\u010dasn\u011b narozen\u00e9ho d\u00edt\u011bte. Preferuj\u00ed se alternativn\u00ed antihypertenziva (propranolol, nifedipin), pokud je to mo\u017en\u00e9.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Lithium \u2014 KRITICK\u00c1 INTERAKCE.<\/strong> Thiazidy sni\u017euj\u00ed ren\u00e1ln\u00ed clearance lithia a mohou vyvolat toxicitu lithia. Pokud je to mo\u017en\u00e9, kombinaci se vyhn\u011bte; pokud je to nevyhnuteln\u00e9, monitorujte hladiny lithia t\u00fddn\u011b po prvn\u00ed m\u011bs\u00edc a sni\u017ete d\u00e1vku lithia o 25\u201350 %.<\/li>\n<li><strong>NSAID \u2014 riziko \u201ctrojit\u00e9ho \u00faderu\u201d.<\/strong> ARB + diuretikum + NSAID = vysok\u00e9 riziko AKI p\u0159i hypovol\u00e9mii nebo sou\u010dasn\u00e9m onemocn\u011bn\u00ed (infekce, dehydratace). Omezte NSAID na ob\u010dasn\u00e9 kr\u00e1tkodob\u00e9 u\u017e\u00edv\u00e1n\u00ed; preferuje se paracetamol.<\/li>\n<li><strong>Dopl\u0148ky drasl\u00edku, \u0161et\u0159\u00edc\u00ed diuretika (spironolakton, eplerenon, amilorid)<\/strong> \u2014 hyperkal\u00e9mie navzdory ztr\u00e1t\u011b drasl\u00edku zp\u016fsoben\u00e9 HCTZ. Pe\u010dliv\u011b monitorujte.<\/li>\n<li><strong>Digoxin<\/strong> \u2014 hypokal\u00e9mie vyvolan\u00e1 HCTZ zvy\u0161uje toxicitu digoxinu. Monitorujte hladiny drasl\u00edku a digoxinu.<\/li>\n<li><strong>Peror\u00e1ln\u00ed kortikosteroidy<\/strong> \u2014 aditivn\u00ed hypokal\u00e9mie a retence tekutin (\u010d\u00e1ste\u010dn\u011b kompenzuj\u00edc\u00ed \u00fa\u010dinek thiazid\u016f)<\/li>\n<li><strong>Amfotericin B, stimula\u010dn\u00ed laxativa<\/strong> \u2014 riziko aditivn\u00ed hypokal\u00e9mie<\/li>\n<li><strong>Peror\u00e1ln\u00ed antidiabetika, inzulin<\/strong> \u2014 thiazidy zhor\u0161uj\u00ed gluk\u00f3zovou toleranci; u diabetik\u016f m\u016f\u017ee HbA1c vzr\u016fst o 0,1\u20130,3 %. M\u00e9n\u011b v\u00fdrazn\u00fd probl\u00e9m u kombinace telmisartan+HCTZ ne\u017e u jin\u00fdch kombinac\u00ed ARB+HCTZ (PPAR-\u03b3 aktivita telmisartanu \u010d\u00e1ste\u010dn\u011b kompenzuje \u00fa\u010dinek thiazid\u016f).<\/li>\n<li><strong>Cholestyramin \/ colestipol<\/strong> \u2014 sni\u017euj\u00ed absorpci HCTZ o 40\u201385 %. Pod\u00e1vejte s odstupem 4 hodin.<\/li>\n<li><strong>Alkohol<\/strong> \u2014 aditivn\u00ed ortostatick\u00e1 hypotenze, zejm\u00e9na p\u0159i titraci d\u00e1vky<\/li>\n<li><strong>Fluconazole, rifampicin<\/strong> &mdash; affect CYP2C9\/3A4 activation of losartan to E-3174 metabolite; may alter BP effect<\/li>\n<li><strong>Jin\u00e9 ACE inhibitory, jin\u00e9 ARB, aliskiren<\/strong> \u2014 nekombinovat<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cozartan-H vs ARB Monotherapy &mdash; When to Step Up<\/h2>\n<p>Cozartan-H is a <strong>l\u00e9k 2. volby<\/strong>, nikoli prvn\u00ed volby. U nov\u011b diagnostikovan\u00e9 hypertenze bez komplikac\u00ed:<\/p>\n<ol>\n<li><strong>Start<\/strong> s <a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar<\/a> (losartan monotherapy) (or a calcium-channel blocker; or an ACE inhibitor if no ACEi-cough history)<\/li>\n<li><strong>Titrovat<\/strong> na c\u00edlovou d\u00e1vku b\u011bhem 4-6 t\u00fddn\u016f<\/li>\n<li><strong>Pokud TK st\u00e1le nekontrolov\u00e1n<\/strong>, move to Cozartan-H (ARB + thiazide) <strong>nebo<\/strong> p\u0159idat blok\u00e1tor kalciov\u00fdch kan\u00e1l\u016f (ARB + BKK). Ob\u011b kombinace jsou podlo\u017eeny d\u016fkazy.<\/li>\n<li><strong>Pokud TK st\u00e1le nekontrolov\u00e1n po 4-6 t\u00fddnech na kombinaci<\/strong>, p\u0159ej\u00edt na trojkombinaci: ARB + BKK + thiazid<\/li>\n<li><strong>Po trojkombinaci<\/strong>, p\u0159idat spironolakton (d\u016fkazy z studie PATHWAY-2 pro rezistentn\u00ed hypertenzi) nebo odeslat ke specialistovi (sten\u00f3za ren\u00e1ln\u00ed tepny, prim\u00e1rn\u00ed hyperaldosteronismus, feochromocytom)<\/li>\n<\/ol>\n<p>Patients with uncomplicated stage 2 hypertension (&ge;160\/100) may reasonably start directly on Cozartan-H &mdash; current AHA\/ACC guidelines prefer early two-drug initiation for severe hypertension over single-drug titration.<\/p>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Store Cozartan-H below 25&deg;C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Is Cozartan-H a first-line blood-pressure drug?<\/h3>\n<p>Ne \u2014 fixn\u00ed kombinace ARB\/thiazid nejsou <strong>l\u00e9ky druh\u00e9 volby<\/strong>. Standardn\u00ed postup je za\u010d\u00edt s monoterapi\u00ed ARB (<a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar<\/a> (losartan monotherapy)), titrate to target dose, and move to Cozartan-H only if BP is not controlled after 4-6 weeks. An exception: stage 2 hypertension (&ge;160\/100) can reasonably start on two-drug therapy directly per AHA\/ACC guidelines.<\/p>\n<h3 class=\"wp-block-heading\">When should I take Cozartan-H &mdash; morning or evening?<\/h3>\n<p><strong>R\u00e1no<\/strong> je v\u00fdchoz\u00ed volba. Slo\u017eka HCTZ je diuretikum \u2014 zvy\u0161uje tvorbu mo\u010di po dobu 2-4 hodin po pod\u00e1n\u00ed. Ve\u010dern\u00ed pod\u00e1n\u00ed m\u016f\u017ee naru\u0161it sp\u00e1nek no\u010dn\u00edm mo\u010den\u00edm. N\u011bkter\u00fdm pacient\u016fm s no\u010dn\u00ed hypertenz\u00ed (nedostate\u010dn\u00fd no\u010dn\u00ed pokles tlaku, chronick\u00e9 onemocn\u011bn\u00ed ledvin) m\u016f\u017ee b\u00fdt doporu\u010deno p\u0159ej\u00edt na ve\u010dern\u00ed pod\u00e1n\u00ed k ovlivn\u011bn\u00ed rann\u00edho krevn\u00edho tlaku; konzultujte se sv\u00fdm l\u00e9ka\u0159em.<\/p>\n<h3 class=\"wp-block-heading\">O kolik v\u011bt\u0161\u00ed pokles krevn\u00edho tlaku mohu o\u010dek\u00e1vat oproti <a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar<\/a> (losartan monotherapy) alone?<\/h3>\n<p>P\u0159ibli\u017en\u011b <strong>v pr\u016fm\u011bru o 5-10 mmHg systolick\u00e9ho a 3-6 mmHg diastolick\u00e9ho tlaku nav\u00edc<\/strong> on average, measured 4-6 weeks after starting Cozartan-H. The additive effect comes from blocking the compensatory RAAS activation that normally blunts thiazide monotherapy; that blockade unlocks HCTZ&rsquo;s full effect.<\/p>\n<h3 class=\"wp-block-heading\">My potassium is normal on an ARB &mdash; will it drop on Cozartan-H?<\/h3>\n<p>Obvykle z\u016fst\u00e1v\u00e1 v norm\u00e1ln\u00edm rozmez\u00ed. Ztr\u00e1ta drasl\u00edku zp\u016fsoben\u00e1 thiazidy je <strong>\u010d\u00e1ste\u010dn\u011b kompenzov\u00e1na tendenc\u00ed ARB zvy\u0161ovat drasl\u00edk<\/strong>. A small number of patients do develop hypokalaemia &mdash; baseline and 1-2 week follow-up U&amp;E is routine. If potassium drops below 3.5, add a potassium-sparing strategy (eplerenone, a potassium-rich diet, or occasionally potassium supplementation) rather than stopping Cozartan-H.<\/p>\n<h3 class=\"wp-block-heading\">Will Cozartan-H raise my uric acid or trigger gout?<\/h3>\n<p>Losartan uniquely <strong>sni\u017euje<\/strong> serum uric acid by inhibiting URAT1 in the proximal tubule, which <strong>partially offsets<\/strong> HCTZ&rsquo;s urate-raising effect. Losartan + HCTZ is the <strong>preferred ARB+thiazide combination for patients with gout or hyperuricaemia<\/strong>. New-onset gout on Cozartan-H is uncommon but possible in high-risk patients (CKD, male, alcohol, obesity).<\/p>\n<h3 class=\"wp-block-heading\">I have type 2 diabetes &mdash; is Cozartan-H safe?<\/h3>\n<p>Ano, ale m\u011bjte na pam\u011bti, \u017ee <strong>thiazidy m\u00edrn\u011b zhor\u0161uj\u00ed gluk\u00f3zovou toleranci<\/strong> (average fasting-glucose rise 5-8 mg\/dL, HbA1c rise 0.1-0.3%). The BP benefit outweighs this effect in most diabetics, and tighter BP control reduces diabetic kidney and eye complications more than the glucose rise increases them. Monitor HbA1c annually. If diabetic control worsens on Cozartan-H, ask about switching to <a href=\"https:\/\/medsbase.com\/cs\/telma-h\/\">Telma H<\/a> (telmisartan + HCTZ), kter\u00fd m\u00e1 \u010d\u00e1ste\u010dnou metabolicky protektivn\u00ed aktivitu.<\/p>\n<h3 class=\"wp-block-heading\">Can I take ibuprofen with Cozartan-H?<\/h3>\n<p>Ob\u010dasn\u00e9 kr\u00e1tkodob\u00e9 u\u017e\u00edv\u00e1n\u00ed je obvykle v po\u0159\u00e1dku. <strong>Chronick\u00e9 denn\u00ed u\u017e\u00edv\u00e1n\u00ed NSAID<\/strong> (ibuprofen, diklofenak, naproxen) je rizikov\u00e9 v kombinaci s jak\u00fdmkoli ARB + diuretikem \u2014 tzv. \u201ctrojit\u00e1 r\u00e1na\u201d (ARB + diuretikum + NSAID) m\u016f\u017ee vyvolat akutn\u00ed po\u0161kozen\u00ed ledvin p\u0159i dehydrataci, infekci nebo operaci. P\u0159i chronick\u00e9 bolesti u\u017e\u00edvejte paracetamol; p\u0159i z\u00e1n\u011btu proberte alternativy se sv\u00fdm l\u00e9ka\u0159em.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Cozartan-H in pregnancy?<\/h3>\n<p><strong>Ne \u2014 absolutn\u011b kontraindikov\u00e1no.<\/strong> Ob\u011b slo\u017eky jsou teratogenn\u00ed: ARB zp\u016fsobuje fet\u00e1ln\u00ed ren\u00e1ln\u00ed agenezi a oligohydramnion; HCTZ proch\u00e1z\u00ed placentou a m\u016f\u017ee zp\u016fsobit fet\u00e1ln\u00ed nebo novorozeneckou \u017eloutenku a trombocytopenii. \u017deny v reproduk\u010dn\u00edm v\u011bku by m\u011bly pou\u017e\u00edvat spolehlivou antikoncepci. Pro ty, kter\u00e9 pl\u00e1nuj\u00ed t\u011bhotenstv\u00ed, p\u0159ejd\u011bte na <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, methyldopu nebo nifedipin <strong>p\u0159ed po\u010det\u00edm<\/strong>.<\/p>\n<h3 class=\"wp-block-heading\">Will I need to urinate more at night on Cozartan-H?<\/h3>\n<p>Obvykle ne, pokud tabletu u\u017e\u00edv\u00e1te r\u00e1no. Diuretick\u00fd \u00fa\u010dinek vrchol\u00ed 2-4 hodiny po pod\u00e1n\u00ed a ve\u010der je v\u011bt\u0161inou ji\u017e pry\u010d. Pacienti, kte\u0159\u00ed p\u0159ejdou na ve\u010dern\u00ed d\u00e1vkov\u00e1n\u00ed, \u010dasto poci\u0165uj\u00ed nokturii; n\u00e1vrat k rann\u00edmu d\u00e1vkov\u00e1n\u00ed tento probl\u00e9m vy\u0159e\u0161\u00ed b\u011bhem 1-3 dn\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p>Vezm\u011bte si ji, jakmile si vzpomenete, pokud to nen\u00ed n\u011bkolik hodin p\u0159ed dal\u0161\u00ed d\u00e1vkou \u2014 v tom p\u0159\u00edpad\u011b vynechejte vynechanou d\u00e1vku a pokra\u010dujte v obvykl\u00e9m re\u017eimu. Ned\u00e1vejte si dvojitou d\u00e1vku. Jedna vynechan\u00e1 d\u00e1vka nem\u00e1 v\u00fdznamn\u00fd vliv na kontrolu krevn\u00edho tlaku. Pokud vynech\u00e1te v\u00edce ne\u017e 2 dny, v\u00e1\u0161 krevn\u00ed tlak za\u010dne op\u011bt stoupat; pokra\u010dujte v obvykl\u00e9 d\u00e1vce (nen\u00ed t\u0159eba zvy\u0161ovat).<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Cozartan-H online?<\/h3>\n<p>You can buy Cozartan-H (50\/12.5 mg losartan + HCTZ, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed antihypertenziva na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aquazide\/\">Aquazide \u2014 Hydrochlorothiazid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/coversyl\/\">Coversyl &mdash; Perindopril (ACEi alternative)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/diovan-160\/\">Diovan 160 \u2014 Valsartan 160 mg (monoterapie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/olmezest-am\/\">Olmezest AM \u2014 Olmesartan + Amlodipine<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">Ramcor \u2014 Ramipril (alternativa ACE inhibitoru)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/valzaar-h\/\">Valzaar H \u2014 Valsartan + HCTZ<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na vysok\u00fd krevn\u00ed tlak<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Hypertenze, srde\u010dn\u00ed selh\u00e1n\u00ed a arytmie vy\u017eaduj\u00ed diagn\u00f3zu, monitorov\u00e1n\u00ed a individu\u00e1ln\u00ed d\u00e1vkov\u00e1n\u00ed l\u00e9ka\u0159em \u2014 v\u017edy u\u017e\u00edvejte betablok\u00e1tory pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/betnesol-tab\/\">Betnesol Tab<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/valent\/\">Valent<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/coversyl\/\">Coversyl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/app-up\/\">App-Up<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/foracort-inhaler\/\">Foracort Inhaler<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Cozartan-H is Torrent&#8217;s fixed-dose losartan 50 mg + HCTZ 12.5 mg tablets \u2014 second-line combination for patients whose blood pressure is not controlled on losartan alone. The losartan component is uniquely uricosuric, offsetting HCTZ&#8217;s urate-raising effect, making this combination preferred in patients with hypertension plus gout or hyperuricaemia. Once-daily morning dosing.<\/p>","protected":false},"featured_media":58473,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3342,3260,3356],"product_tag":[4500,3401,3384],"class_list":{"0":"post-58472","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-general-health","9":"product_cat-heart-blood-pressure","10":"product_cat-high-blood-pressure-medication","11":"product_tag-cozartan-h","12":"product_tag-hydrochlorothiazide","13":"product_tag-losartan","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/58472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=58472"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/58473"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=58472"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=58472"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=58472"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=58472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}